Unlocking Precision Oncology: The Power of Molecular and EHR Data Integration in Community Oncology Settings

 

In this on-demand webinar, discover how combining molecular profiling (WES, WTS, IHC) with longitudinal clinical data from community oncology practices can improve target discovery, biomarker strategy and clinical development.  

Experts from Caris Life Sciences, Oncology Hematology Care and Ontada discuss how integrated data is driving smarter decisions in oncology across the drug development lifecycle, including how to: 

  • Identify novel molecular targets and vulnerabilities
  • Prioritize indications, patient populations and biomarkers
  • Uncover pan-tumor insights to guide therapeutic strategy
  • Design more effective clinical development plans

Panelists include: 

  • George W. Sledge, Jr., MD, executive vice president and chief medical officer, Caris Life Sciences
  • David Waterhouse, MD, MPH, chief innovation officer, Oncology Hematology Care 
  • Amy K. O'Sullivan, PhD, SVP and chief research officer, Ontada
  • Emily Paul, PhD, moderator; director, life science product and platform development, Ontada

Watch the webinar to learn how integrated data is shaping the future of precision oncology.